BGT Stock Overview
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Bio-Gene Technology Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.072 |
52 Week High | AU$0.13 |
52 Week Low | AU$0.038 |
Beta | 0.35 |
1 Month Change | 63.64% |
3 Month Change | 20.00% |
1 Year Change | -10.00% |
3 Year Change | -46.67% |
5 Year Change | -25.77% |
Change since IPO | -64.00% |
Recent News & Updates
Recent updates
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely
Feb 22Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation
Oct 25Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation
Jun 20Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future
Apr 28What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation
Jan 11Shareholder Returns
BGT | AU Chemicals | AU Market | |
---|---|---|---|
7D | 20.0% | 0.6% | 1.5% |
1Y | -10.0% | -4.9% | 11.6% |
Return vs Industry: BGT underperformed the Australian Chemicals industry which returned -4.9% over the past year.
Return vs Market: BGT underperformed the Australian Market which returned 11.6% over the past year.
Price Volatility
BGT volatility | |
---|---|
BGT Average Weekly Movement | 14.8% |
Chemicals Industry Average Movement | 10.1% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 17.1% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: BGT's share price has been volatile over the past 3 months.
Volatility Over Time: BGT's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | n/a | Tim Grogan | https://www.bio-gene.com.au |
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University to refine the process for oil extraction; and with BASF, Grains Research and Development Corporation, and Queensland Department of Agriculture and Fisheries for testing of Flavocide in grain storage.
Bio-Gene Technology Limited Fundamentals Summary
BGT fundamental statistics | |
---|---|
Market cap | AU$14.10m |
Earnings (TTM) | -AU$2.63m |
Revenue (TTM) | AU$167.99k |
86.3x
P/S Ratio-5.5x
P/E RatioIs BGT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BGT income statement (TTM) | |
---|---|
Revenue | AU$167.99k |
Cost of Revenue | AU$323.57k |
Gross Profit | -AU$155.58k |
Other Expenses | AU$2.48m |
Earnings | -AU$2.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.013 |
Gross Margin | -92.61% |
Net Profit Margin | -1,568.35% |
Debt/Equity Ratio | 0% |
How did BGT perform over the long term?
See historical performance and comparison